CRM

Salesforce

$229.79

-2.09%
Oct 5, 2026
Bobby Quantitative Model
Salesforce, Inc. is the world's leading provider of enterprise cloud computing solutions, delivering customer relationship management (CRM) technology through its Customer 360 platform, which unifies sales, service, marketing, commerce, and data integration (MuleSoft) for businesses worldwide. The company is a dominant platform player in the software-as-a-service (SaaS) industry, with a vast ecosystem of applications and a first-mover advantage in cloud-based CRM. The current investor narrative centers on Salesforce's aggressive AI push, particularly its Agentforce platform, and a massive $25 billion share repurchase program that management framed as a bet against the 'SaaSpocalypse'—a feared AI-driven disruption of traditional SaaS models. Recent headlines highlight a strategic partnership with Anthropic that turned a potential AI threat into a growth opportunity, alongside blowout Q2 earnings that sent the stock soaring over 20% in late August 2026. However, debate persists over whether AI monetization can sustain growth amid intensifying competition from Microsoft and ServiceNow, and whether the stock's sharp rally has already priced in these optimistic expectations.

People also watch

Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series B Mandatory Convertible Preferred Stock

Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series B Mandatory Convertible Preferred Stock

GOOGN

Analysis
Sarcos

Sarcos

STRC

Analysis
Boost Run Inc. Class A Common Stock

Boost Run Inc. Class A Common Stock

BRUN

Analysis
Uber

Uber

UBER

Analysis
ServiceNow

ServiceNow

NOW

Analysis

BobbyInvestment Opinion: Should I buy CRM Today?

Based on the synthesis of analyst consensus, valuation, and growth prospects, CRM earns a Buy rating. The core thesis is that Salesforce is undervalued relative to its AI-driven growth potential and cash generation, with the average analyst target of $283.36 implying 20.7% upside. The consensus recommendation of 'Buy' (mean rating 1.76) from 54 analysts supports this view, though the wide target range ($160–$475) reflects uncertainty.

The supporting evidence is compelling: the forward PE of 14.66x is less than half the industry average of 35x, and the PS ratio of 4.86x is below the sector's 8–10x. Revenue grew 10.83% year-over-year in Q2 FY2027, with net margin expanding to 31.08% from 17.35% in Q4 FY2026. Free cash flow of $15.154 billion provides a 7.5% yield, and the $25 billion buyback program demonstrates management's confidence. The Anthropic partnership further de-risks the AI disruption narrative.

Key risks include margin compression (operating margin fell to 20.55% in Q2 from 21.88% in Q4), intense competition from Microsoft and ServiceNow, and high volatility (beta 1.202). The rating would upgrade to Strong Buy if revenue growth accelerates above 15% or if the forward PE remains below 15x with improving margins. It would downgrade to Hold if growth falls below 8% or if operating margins drop below 20%. At 14.66x forward earnings, the stock is undervalued relative to its history and peers, offering a favorable risk/reward for patient investors.

Sign up to view all

CRM 12-Month Price Forecast

Salesforce presents a compelling risk/reward with its discounted forward valuation and strong cash generation, but the recent 8.66% monthly decline and margin compression warrant caution. The Anthropic partnership and AI initiatives could drive multiple expansion if they accelerate growth, but competition and execution risks remain. I would upgrade to high confidence if revenue growth exceeds 12% or if operating margins stabilize above 21%. A downgrade would occur if growth falls below 8% or if the stock breaks below $200, signaling a loss of confidence in the AI narrative.

Historical Price
Current Price $229.79
Average Target $275.00
High Target $350.00
Low Target $160.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $283.36 and implied upside of +23.3% versus the current price.

Average Target

$283.36

0 analysts

Implied Upside

+23.3%

vs. current price

Analyst Count

—

covering this stock

Price Range

$160 - $475

Analyst target range

Salesforce is covered by 54 analysts, with a consensus recommendation of 'Buy' (mean rating of 1.76, where 1 is Strong Buy and 5 is Strong Sell). The average target price is $283.36, implying an upside of approximately 20.7% from the current price of $234.69. The consensus leans bullish, with a majority of analysts maintaining positive ratings, as evidenced by recent institutional ratings from firms like Citizens (Market Outperform), BMO Capital (Outperform), and Stifel (Buy), though some maintain neutral stances (e.g., Wells Fargo, RBC Capital, Citigroup). The bullish sentiment is driven by AI-driven growth prospects and the company's strong cash flow, but the recent 1-month decline of 8.66% may have tempered short-term optimism. The target price range spans from a low of $160 to a high of $475, a wide spread of $315, indicating significant disagreement among analysts about the company's future. The high target of $475 assumes successful AI monetization, multiple expansion, and accelerating growth, potentially driven by Agentforce adoption and the Anthropic partnership. The low target of $160 prices in margin compression, competitive losses, or a broader economic downturn that could slow SaaS spending. The wide spread signals high uncertainty, but the clustering of targets around the average suggests moderate conviction. Recent analyst actions have been mostly reiterations rather than upgrades or downgrades, with no major changes in September 2026, indicating a wait-and-see approach ahead of upcoming earnings or product announcements.

Drowning in data?

Find the real signal!

Bulls vs Bears: CRM Investment Factors

The bull case for Salesforce rests on its attractive forward valuation (14.66x PE), massive buyback program, and the Anthropic partnership that mitigates AI disruption fears. However, the bear case highlights the recent 8.66% monthly decline, margin compression, and intense competition that could cap growth. Currently, the bull evidence appears slightly stronger due to the compelling valuation and analyst consensus, but the most critical tension is whether AI monetization can reaccelerate revenue growth above 10.83% and reverse the recent margin decline. If AI upsells fail to materialize, the stock could retest its 52-week low; if they succeed, the forward PE could expand toward the industry average.

Bullish

  • AI Partnership Turns Threat into Growth: The strategic partnership with Anthropic, announced in early September 2026, directly addresses the 'SaaSpocalypse' narrative by converting a potential AI disruptor into a distribution channel. This has already contributed to AI-related upsells, helping drive Q2 FY2027 revenue of $11.345 billion, up 10.83% year-over-year.
  • Massive Buyback Signals Undervaluation: Salesforce repurchased $27.248 billion of stock in Q1 FY2027 and $84 million in Q2, part of a $25 billion program framed as a bet against AI disruption. This aggressive capital return, combined with a 7.5% free cash flow yield, suggests management views the shares as deeply undervalued.
  • Attractive Forward Valuation: The forward PE of 14.66x is significantly below the industry average of 35x and near the bottom of its historical range (10.70x–47.99x). The PS ratio of 4.86x is also well below the sector's 8–10x, implying the market is pricing in conservative growth expectations that could be exceeded.
  • Strong Profitability and Cash Generation: Q2 FY2027 net margin reached 31.08%, a sharp improvement from 18.93% in Q1 and 17.35% in Q4 FY2026. Free cash flow for the trailing twelve months was $15.154 billion, providing ample liquidity to fund growth, dividends, and buybacks.

Bearish

  • Recent Pullback Signals Momentum Loss: Despite a 41.29% three-month gain, the stock has declined 8.66% in the past month, underperforming the S&P 500 by 9.25 percentage points. This sharp reversal from the August highs suggests the post-earnings rally may be losing steam.
  • Valuation Discount Reflects Real Concerns: The trailing PE of 27.04x is a 23% discount to the industry average, but this may be justified given the modest 10.83% revenue growth and intense competition. The market appears skeptical that AI monetization can accelerate growth to levels that would warrant a premium multiple.
  • Margin Compression in Q2: Operating margin declined to 20.55% in Q2 FY2027 from 21.80% in Q1 and 21.88% in Q4 FY2026, due to higher R&D and SG&A expenses. If this trend continues, it could pressure earnings and undermine the bull case for multiple expansion.
  • High Volatility and Drawdown Risk: With a beta of 1.202, the stock is 20.2% more volatile than the market, and it experienced a maximum drawdown of 43.61% over the past year. The 52-week low of $146.32 represents a potential 37.7% downside from the current price if market conditions deteriorate.

CRM Technical Analysis

Salesforce's stock is in a recovery phase within a broader range-bound consolidation, with a 1-year price change of -1.754% and a year-to-date decline of 7.46%. The current price of $234.69 sits at approximately 72% of its 52-week range (low of $146.32, high of $269.11), indicating a mid-to-upper positioning that reflects improving momentum but not overextension. This placement suggests the stock has recovered from its lows but still faces overhead resistance near the highs, implying a neutral-to-bullish bias with room for further upside if momentum persists. Over the past three months, the stock has surged 41.29%, significantly outperforming the S&P 500's 3.34% gain, with a relative strength of 37.95 percentage points. However, the 1-month change is -8.66%, diverging sharply from the 3-month uptrend and underperforming the S&P 500's 0.59% gain by 9.25 percentage points, signaling a recent pullback that could be a temporary consolidation or the start of a trend reversal. The 6-month change of 25.38% further confirms the strong medium-term momentum, but the negative 1-month and 1-year changes highlight the stock's volatility and the potential for mean reversion. Key technical levels include support at the 52-week low of $146.32, which if broken could trigger a deeper selloff, and resistance at the 52-week high of $269.11, a breakout above which would signal renewed bullish conviction. The stock's beta of 1.202 indicates it is 20.2% more volatile than the market, meaning investors should expect amplified moves relative to the S&P 500; this is critical for position sizing and risk management, especially given the recent 8.66% monthly decline and a maximum drawdown of 43.61% over the past year.

Beta

1.26

1.26x market volatility

Max Drawdown

-43.6%

Largest decline past year

52-Week Range

$146-$269

Price range past year

Annual Return

-4.4%

Cumulative gain past year

PeriodCRM ReturnS&P 500
1m-11.4%+0.6%
3m+35.6%+3.6%
6m+30.3%+14.6%
1y-4.4%+15.8%
ytd-9.4%+13.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CRM Fundamental Analysis

Salesforce's revenue trajectory remains solid, with the most recent quarter (Q2 FY2027, ended July 31, 2026) reporting revenue of $11.345 billion, representing a 10.83% year-over-year growth rate. This growth is driven primarily by the Subscription and Support segment, which generated $10.82 billion (95.4% of total revenue), while Professional Services and Other contributed $525 million. Sequentially, revenue increased from $11.133 billion in Q1 FY2027 and $11.201 billion in Q4 FY2026, indicating a steady, albeit modest, acceleration in growth, likely fueled by AI-related upsells and the Anthropic partnership. The consistent double-digit growth, despite a challenging macro environment, underscores the resilience of Salesforce's recurring revenue model and its ability to monetize its AI investments. The company is highly profitable, with Q2 FY2027 net income of $3.526 billion and a net margin of 31.08%, a significant improvement from 18.93% in Q1 FY2027 and 17.35% in Q4 FY2026. Gross margin stood at 76.65% in Q2, down slightly from 76.92% in Q1 but up from 77.61% in Q4 FY2026, reflecting a stable pricing environment and cost efficiencies. Operating margin was 20.55% in Q2, compared to 21.80% in Q1 and 21.88% in Q4 FY2026, indicating some compression due to higher operating expenses, particularly in R&D and SG&A, but overall profitability remains robust for a software company of this scale. Salesforce's balance sheet is healthy, with a debt-to-equity ratio of 0.29, well below the industry average, and a current ratio of 0.76, which is low but typical for a company with substantial deferred revenue. Free cash flow (FCF) for the trailing twelve months was $15.154 billion, providing ample liquidity to fund growth, dividends ($364 million paid in Q2), and share repurchases ($84 million in Q2, though a massive $27.248 billion was repurchased in Q1). The FCF yield, based on a market cap of $201.68 billion, is approximately 7.5%, indicating strong cash generation relative to valuation. Return on equity (ROE) was 12.61%, and return on assets (ROA) was 5.70%, both solid for a mature software company, suggesting efficient capital allocation.

Quarterly Revenue

$11.3B

2026-07

Revenue YoY Growth

+10.8%

YoY Comparison

Gross Margin

76.6%

Latest Quarter

Free Cash Flow

$15.2B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Subscription and Support
Professional Services and Other

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CRM Overvalued?

Since Salesforce is profitable with trailing net income of $3.526 billion in Q2 FY2027, the PE ratio is the primary valuation metric. The trailing PE is 27.04x, while the forward PE is 14.66x, implying the market expects significant earnings growth—likely driven by AI monetization and margin expansion—that would compress the multiple. This large gap between trailing and forward PE suggests that analysts anticipate robust EPS growth, with estimated EPS averaging $25.37 for the next fiscal year, up from the current trailing EPS of $4.30 (quarterly). Compared to the industry average PE of approximately 35x for application software, Salesforce trades at a discount of about 23% on a trailing basis, but the forward PE of 14.66x is significantly below the sector, potentially indicating undervaluation if growth targets are met. The PS ratio of 4.86x is also below the industry average of 8-10x, further supporting a value argument. However, the premium/discount assessment must consider Salesforce's growth rate (10.8% YoY) and profitability (net margin 31.1%), which are superior to many peers; thus, the discount may reflect concerns about AI disruption and competitive pressures rather than fundamental weaknesses. Historically, Salesforce's PE ratio has ranged from a low of 10.70x in Q2 FY2027 to a high of 47.99x in Q4 FY2025, with the current trailing PE of 27.04x sitting near the middle of that range. The PS ratio of 4.86x is near the low end of its historical band (13.30x to 32.79x), suggesting that the stock is currently valued more attractively relative to its own history. This could be a value opportunity if the company continues to execute on AI and margin expansion, but it also reflects the market's skepticism about future growth, especially given the recent pullback. The forward PE of 14.66x is near the bottom of its historical range, implying that the market is pricing in conservative expectations, which could lead to multiple expansion if earnings beat.

PE

27.0x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 11x~247x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

16.1x

Enterprise Value Multiple

Investment Risk Disclosure

Salesforce faces financial risks primarily from its modest revenue growth of 10.83% year-over-year, which may not justify its trailing PE of 27.04x if growth decelerates further. The company's operating margin compressed to 20.55% in Q2 FY2027 from 21.88% in Q4 FY2026, indicating rising costs that could erode profitability. Additionally, a current ratio of 0.76 is low, though typical for software companies with high deferred revenue, and the debt-to-equity ratio of 0.29 is manageable but not negligible. The $27.248 billion buyback in Q1 FY2027 reduced shares outstanding but also depleted cash that could have been used for AI investments.

Market and competitive risks are significant, with a beta of 1.202 meaning the stock is 20.2% more volatile than the market, amplifying downside during selloffs. The forward PE of 14.66x is a discount to peers, but this could persist if competition from Microsoft and ServiceNow intensifies, as seen in ServiceNow's recent Aramco partnership. Regulatory headwinds in the SaaS sector, such as data privacy laws, could increase compliance costs. The recent 8.66% monthly decline and 9.25 percentage point underperformance versus the S&P 500 highlight vulnerability to sector rotation, especially if AI enthusiasm wanes.

The worst-case scenario involves a combination of slowing AI adoption, margin compression, and competitive losses, leading to a revenue growth deceleration below 8% and a PE compression to the low end of its historical range (10.70x). This could drive the stock toward its 52-week low of $146.32, representing a 37.7% decline from the current price of $234.69. The analyst low target of $160 implies a 31.8% downside, and the maximum drawdown of 43.61% over the past year shows the potential severity. Investors could lose over a third of their capital in this adverse scenario, especially if the Anthropic partnership fails to deliver expected upsells.

FAQ

The most severe risk is competitive disruption from Microsoft and ServiceNow, which could slow revenue growth below the current 10.83% and pressure margins. Financial risks include operating margin compression, which fell to 20.55% in Q2 FY2027 from 21.88% in Q4 FY2026, and a low current ratio of 0.76. Macro risks are amplified by the stock's beta of 1.202, making it 20.2% more volatile than the market. Company-specific risks include the failure of AI monetization efforts, such as the Anthropic partnership, to generate expected upsells. Additionally, the stock's maximum drawdown of 43.61% over the past year highlights the potential for significant losses in adverse conditions.

The 12-month forecast is based on three scenarios: a bull case (25% probability) targeting $300–$350, a base case (55% probability) targeting $260–$290, and a bear case (20% probability) targeting $160–$200. The base case is most likely, assuming steady revenue growth around 10-11% and stable margins, leading the stock toward the analyst average target of $283.36. The bull case requires successful AI monetization and multiple expansion, while the bear case assumes growth deceleration and competitive losses. Key catalysts include Q3 earnings, AI product adoption, and buyback execution.

CRM appears undervalued on both absolute and relative bases. The trailing PE of 27.04x is a 23% discount to the industry average of 35x, and the forward PE of 14.66x is near the bottom of its historical range (10.70x–47.99x). The PS ratio of 4.86x is also below the sector's 8–10x and near the low end of its own historical band. This discount suggests the market is pricing in conservative growth expectations, possibly due to AI disruption fears. If Salesforce can sustain double-digit revenue growth and expand margins, the multiple could expand toward the industry average, implying significant upside.

From a risk/reward perspective, CRM appears attractive for long-term investors, with the average analyst target of $283.36 implying 20.7% upside from the current price of $234.69. The forward PE of 14.66x is well below the industry average of 35x, and the company generates strong free cash flow of $15.154 billion. However, the recent 8.66% monthly decline and high beta of 1.202 mean short-term volatility could persist. The biggest downside risk is a retest of the 52-week low at $146.32, representing a 37.7% loss. It is a good buy for patient investors who believe in the AI monetization story and can tolerate volatility, but those with a short horizon may want to wait for a clearer uptrend.

CRM is more suitable for long-term investment due to its strong cash generation, discounted valuation, and AI growth potential, which may take several quarters to fully materialize. The stock's beta of 1.202 and recent 8.66% monthly decline indicate high short-term volatility, making it less ideal for trading. The dividend yield is modest at 0.79%, so income is not a primary focus. A minimum holding period of 2-3 years is recommended to ride out volatility and benefit from AI-driven growth and multiple expansion. Short-term traders could exploit swings, but the risk/reward favors patient investors.